OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study
Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2670-2673
Closed Access | Times Cited: 10
Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2670-2673
Closed Access | Times Cited: 10
Showing 10 citing articles:
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDISTAD
Amy S. Paller, Marjolein de Bruin‐Weller, Danielle Marcoux, et al.
Journal of the American Academy of Dermatology (2024)
Open Access | Times Cited: 3
Amy S. Paller, Marjolein de Bruin‐Weller, Danielle Marcoux, et al.
Journal of the American Academy of Dermatology (2024)
Open Access | Times Cited: 3
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
Niccolò Gori, Alvise Sernicola, Ersilia Tolino, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 7
Niccolò Gori, Alvise Sernicola, Ersilia Tolino, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 7
Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: single-center, retrospective study
Tae Woong Seul, Hyun Woo Park, Hyo Yoon Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Tae Woong Seul, Hyun Woo Park, Hyo Yoon Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
Mariateresa Rossi, Silvia Ferrucci, Piergiacomo Calzavara‐Pinton, et al.
Advances in Therapy (2024)
Open Access | Times Cited: 2
Mariateresa Rossi, Silvia Ferrucci, Piergiacomo Calzavara‐Pinton, et al.
Advances in Therapy (2024)
Open Access | Times Cited: 2
Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis
Lisa P. van der Rijst, Esmé Kamphuis, Marie L. A. Schuttelaar, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 1
Lisa P. van der Rijst, Esmé Kamphuis, Marie L. A. Schuttelaar, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 1
Supervivencia de la ciclosporina en el tratamiento de la dermatitis atópica moderada-grave: Registro Español de Dermatitis Atópica (BIOBADATOP)
C. Couselo-Rodríguez, Ana Batalla, J.M. Carrascosa, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 115, Iss. 4, pp. 341-346
Open Access | Times Cited: 1
C. Couselo-Rodríguez, Ana Batalla, J.M. Carrascosa, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 115, Iss. 4, pp. 341-346
Open Access | Times Cited: 1
[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)
Carmen Couselo‐Rodríguez, Ana Batalla, J.M. Carrascosa, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 4, pp. T341-T346
Open Access
Carmen Couselo‐Rodríguez, Ana Batalla, J.M. Carrascosa, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 4, pp. T341-T346
Open Access
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study
Giuseppe Lauletta, Fabrizio Martora, Francesca di Vico, et al.
Dermatitis (2024)
Closed Access
Giuseppe Lauletta, Fabrizio Martora, Francesca di Vico, et al.
Dermatitis (2024)
Closed Access
Exploring daily practice performance of dupilumab in atopic dermatitis
Lotte S. Spekhorst
(2023)
Open Access
Lotte S. Spekhorst
(2023)
Open Access
